129230-05-3 Usage
Uses
Used in Pharmaceutical Applications:
1,4-bis[(3,4,5-trimethoxyphenyl)carbonyl]piperazin-2-ylmethyl (1,2,2-trimethylpropyl)carbamate is used as a potential therapeutic agent for various medical conditions due to its complex structure and multiple functional groups. 1,4-bis[(3,4,5-trimethoxyphenyl)carbonyl]piperazin-2-ylmethyl (1,2,2-trimethylpropyl)carbamate's specific pharmacological effects and target diseases would need to be determined through additional research.
Used in Chemical Synthesis:
In the chemical industry, 1,4-bis[(3,4,5-trimethoxyphenyl)carbonyl]piperazin-2-ylmethyl (1,2,2-trimethylpropyl)carbamate could be utilized as a building block or intermediate in the synthesis of other complex organic molecules, taking advantage of its diverse functional groups for further reactions and modifications.
Used in Material Science:
1,4-bis[(3,4,5-trimethoxyphenyl)carbonyl]piperazin-2-ylmethyl (1,2,2-trimethylpropyl)carbamate's unique structure may also find applications in material science, potentially serving as a component in the development of new materials with specific properties, such as improved stability, reactivity, or selectivity in various chemical processes.
Check Digit Verification of cas no
The CAS Registry Mumber 129230-05-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,9,2,3 and 0 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 129230-05:
(8*1)+(7*2)+(6*9)+(5*2)+(4*3)+(3*0)+(2*0)+(1*5)=103
103 % 10 = 3
So 129230-05-3 is a valid CAS Registry Number.
129230-05-3Relevant academic research and scientific papers
Design and modeling of new platelet-activating factor antagonists. 1. Synthesis and biological activity of 1,4-bis(3',4',5'-trimethoxybenzoyl)-2- [[(substituted carbonyl and carbamoyl)oxy]methyl]piperazines
Lamouri,Heymans,Tavet,Dive,Batt,Blavet,Braquet,Godfroid
, p. 990 - 1000 (2007/10/02)
To further investigate our hypothesis on the structure of the platelet- activating factor (PAF) receptor, 35 compounds derived from 1,4-bis(3',4',5'- trimethoxybenzoyl)piperazine were synthesized and their in vitro antagonistic effect was measured. Substi
